NCT00606866 2023-11-29
MRI
University of Chicago
Phase 3 Completed
Clinical Trials
6 trialsNCT00941863 2016-03-22
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Bayer
Phase 1 Completed
NCT00510250 2015-07-27
A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
University Health Network, Toronto
Phase 1/2 Completed
NCT00863746 2015-01-19
MISSION
Bayer
Phase 3 Completed
NCT00771147 2012-06-15
PONDIAC
Bayer
Completed
NCT00895674 2010-09-30
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
Bayer
Completed